Mega Matrix Inc. Presented FlexTV New Releases (March 31 - April 4): Springtime Sweet Romance - Contract Marriages, Reunited Lovers, and Family Revelations
SINGAPORE, April 10, 2025 /PRNewswire/ -- From March 31 to April 4, 2025, FlexTV, the global short-drama platform under Mega Matrix Inc. (NYSE American: MPU), released five new English-language dramas. From sweet twists in contract marriages to...
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
YANTAI, China, April 9, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®) in patients with generalized...
LONGi and Raystech Presented at the 2025 Solar & Storage Live Exhibition
BRISBANE, Australia, March 28, 2025 /PRNewswire/ -- LONGi has partnered with Raystech to make a significant appearance at the Solar & Storage Live exhibition, held on March 26-27, 2025, following the announcement of Raystech as the exclusive...
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
- Presented a roadmap to enhance screening reliability at the world's leading multidisciplinary HPV congress held in Portugal from March 16-19 - Demonstrated how self-collected samples for HPV testing can bridge gaps in cervical cancer screening and...
Caravelle International Group Holds Annual General Meeting
HONG KONG, Jan. 4, 2025 /PRNewswire/ -- Caravelle International Group (NASDAQ: HTCO) (the "Company"), a global ocean technology company, announced that the Company's annual shareholder meeting was held on January 3, 2025. At the Annual Meeting, the...
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024
SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with axitinib as first-line...
2024 Design Intelligence Award Held at China Academy of Art, Hangzhou, China
HANGZHOU, China, Dec. 12, 2024 /PRNewswire/ -- The ceremony for the 2024 Design Intelligence Award (DIA) took place on December 6 at the Liangzhu Campus of China Academy of Art (CAA). The Fourier General-Purpose Humanoid Robot GR-1 clinched the...
Tuya Smart Presented at the China Pavilion of COP29, Advocating for a Zero Carbon Future
NEW YORK, Nov. 25, 2024 /PRNewswire/ -- On November 16, 2024, the side event titled "Dialogue with the World: Building a Sustainable Ecosystem for a Zero Carbon Future" took center stage at the China Pavilion of COP29. This event focused on energy...